Biologics License Application
![FDA states that LN-145 in NSCLC is likely to receive accelerated approval](https://pharmtales.com/wp-content/uploads/2023/07/FDA-states-that-LN-145-in-NSCLC-is-likely-to-receive-accelerated-approval.jpg)
FDA states that LN-145 in NSCLC is likely to receive accelerated approval
SG Tylor
Source – Iovance Biotherapeutics The Phase II IOV-LUN-202 trial of LN-145 in patients with post-anti-PD-1 non-small cell lung cancer (NSCLC) ...
![Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345 - USA Pharma News By Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Moderna-Submits-Global-Regulatory-Applications-for-its-RSV-Vaccine-mRNA-1345.jpg)
Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345
SG Tylor
Source – Moderna On July 5, 2023 Moderna, a biotech company at the forefront of mRNA vaccines, shared an update ...